Skip to content
10-K

Annual Report

PASITHEA THERAPEUTICS CORP. KTTA KTTAW

0001213900-26-036434

← back to feed
Filed
Mar 30, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 24, 2026 24.94M sh
Shares Diluted FY 2025 · Dec 31, 2025 7.03M sh
Shares Diluted FY 2025 · Dec 31, 2024 1.1M sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$15.21M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$13.92M
Cash And Equivalents FY 2025 · Dec 31, 2025 $55.16M
Cash And Equivalents FY 2025 · Dec 31, 2024 $6.92M
Stockholders Equity FY 2025 · Dec 31, 2025 $55.22M
Stockholders Equity FY 2025 · Dec 31, 2024 $14.78M
Stockholders Equity FY 2025 · Dec 31, 2023 $23.4M
Current Liabilities FY 2025 · Dec 31, 2025 $4.97M
Current Liabilities FY 2025 · Dec 31, 2024 $1.12M
Total Liabilities FY 2025 · Dec 31, 2025 $5.02M
Total Liabilities FY 2025 · Dec 31, 2024 $1.28M
Current Assets FY 2025 · Dec 31, 2025 $56.46M
Current Assets FY 2025 · Dec 31, 2024 $7.37M
Total Assets FY 2025 · Dec 31, 2025 $60.24M
Total Assets FY 2025 · Dec 31, 2024 $16.06M
Eps Diluted FY 2025 · Dec 31, 2025 −$2.91
Eps Diluted FY 2025 · Dec 31, 2024 −$12.69
Eps Basic FY 2025 · Dec 31, 2025 −$2.91
Eps Basic FY 2025 · Dec 31, 2024 −$12.69
Rd Expense FY 2025 · Dec 31, 2025 $7.98M
Rd Expense FY 2025 · Dec 31, 2024 $7.2M
Net Income FY 2025 · Dec 31, 2025 −$20.43M
Net Income FY 2025 · Dec 31, 2024 −$13.9M
Operating Income FY 2025 · Dec 31, 2025 −$20.86M
Operating Income FY 2025 · Dec 31, 2024 −$14.25M